See more : Adial Pharmaceuticals, Inc. (ADIL) Income Statement Analysis – Financial Results
Complete financial analysis of Noritake Co., Limited (5331.T) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Noritake Co., Limited, a leading company in the Conglomerates industry within the Industrials sector.
- OTRS AG (TR9.F) Income Statement Analysis – Financial Results
- Akar Auto Industries Limited (AAIL.BO) Income Statement Analysis – Financial Results
- The Monarch Cement Company (MCEM) Income Statement Analysis – Financial Results
- Magic Software Enterprises Ltd. (MGIC.TA) Income Statement Analysis – Financial Results
- Rentokil Initial plc (RTO) Income Statement Analysis – Financial Results
Noritake Co., Limited (5331.T)
About Noritake Co., Limited
Noritake Co., Limited manufactures and sells industrial, ceramic and material, tabletop, and engineering products in Japan and internationally. The company offers industrial products, such as abrasive wheels, coated abrasives, diamond and CBN tools, and grinding and polishing related products to automotive, steel, and bearing industries. Its ceramics and materials products include electronic pastes for multilayer ceramic capacitors and other electronic parts; thick film circuit boards for automotive, medical instruments, and light emitting diodes; and vacuum fluorescent displays and ceramic cores. In addition, the company develops and produces various engineering equipment, such as mixers for combining ingredients in chemical, medical, and food products; and filtration systems in grinding and polishing processes, as well as heating equipment for automobiles, electronic components, and energy-related industries. Further, it offers tabletop products comprising tableware for dining. Noritake Co., Limited was founded in 1904 and is headquartered in Nagoya, Japan.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 137.91B | 139.49B | 127.64B | 107.00B | 120.61B | 125.80B | 117.93B | 108.81B | 109.63B | 99.04B | 88.69B | 90.24B | 102.15B | 105.38B | 87.60B | 112.98B | 133.37B | 129.24B | 123.21B | 118.31B |
| Cost of Revenue | 100.08B | 104.14B | 92.57B | 80.33B | 90.05B | 91.85B | 86.48B | 79.54B | 80.39B | 72.86B | 66.15B | 68.86B | 77.98B | 76.39B | 65.66B | 84.08B | 94.21B | 92.03B | 85.89B | 81.49B |
| Gross Profit | 37.84B | 35.36B | 35.07B | 26.67B | 30.57B | 33.95B | 31.44B | 29.27B | 29.25B | 26.18B | 22.54B | 21.38B | 24.17B | 28.99B | 21.94B | 28.91B | 39.15B | 37.21B | 37.32B | 36.82B |
| Gross Profit Ratio | 27.44% | 25.35% | 27.48% | 24.93% | 25.34% | 26.99% | 26.66% | 26.90% | 26.68% | 26.44% | 25.41% | 23.69% | 23.66% | 27.51% | 25.04% | 25.59% | 29.36% | 28.79% | 30.29% | 31.12% |
| Research & Development | 2.31B | 2.38B | 2.32B | 2.29B | 2.57B | 2.55B | 2.49B | 2.44B | 2.80B | 2.97B | 2.72B | 2.92B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 25.20B | 9.27B | 8.87B | 7.96B | 8.37B | 8.42B | 8.80B | 8.55B | 8.13B | 7.20B | 6.33B | 6.17B | 6.37B | 6.88B | 7.67B | 8.01B | 7.90B | 7.39B | 8.03B | 8.60B |
| Selling & Marketing | 599.00M | 17.12B | 16.85B | 16.15B | 17.98B | 18.04B | 17.54B | 17.60B | 17.66B | 16.79B | 15.42B | 15.14B | 15.91B | 17.78B | 15.93B | 20.09B | 20.76B | 20.36B | 20.93B | 21.30B |
| SG&A | 25.80B | 26.39B | 25.72B | 24.12B | 26.36B | 26.47B | 26.35B | 26.15B | 25.80B | 23.99B | 21.75B | 21.31B | 22.29B | 24.66B | 23.60B | 28.10B | 28.66B | 27.74B | 28.96B | 29.90B |
| Other Expenses | -979.00M | 565.00M | 532.00M | 467.00M | 429.00M | 424.00M | 379.00M | 350.00M | 305.00M | 345.00M | 333.00M | 345.00M | 594.00M | 525.00M | 527.00M | 559.00M | 606.00M | 537.00M | 924.00M | 784.00M |
| Operating Expenses | 27.13B | 26.39B | 25.72B | 24.12B | 26.36B | 26.47B | 26.35B | 26.15B | 25.80B | 23.99B | 21.75B | 21.31B | 22.29B | 24.66B | 23.60B | 28.10B | 28.67B | 27.74B | 28.96B | 29.90B |
| Cost & Expenses | 127.20B | 130.52B | 118.29B | 104.44B | 116.40B | 118.32B | 112.83B | 105.69B | 106.18B | 96.85B | 87.90B | 90.17B | 100.27B | 101.05B | 89.26B | 112.18B | 122.88B | 119.78B | 114.85B | 111.39B |
| Interest Income | 297.00M | 146.00M | 44.00M | 75.00M | 133.00M | 126.00M | 104.00M | 93.00M | 67.00M | 50.00M | 48.00M | 47.00M | 58.00M | 47.00M | 56.00M | 102.00M | 149.00M | 115.00M | 40.00M | 31.00M |
| Interest Expense | 20.00M | 26.00M | 25.00M | 26.00M | 20.00M | 33.00M | 59.00M | 75.00M | 145.00M | 160.00M | 158.00M | 150.00M | 155.00M | 156.00M | 191.00M | 199.00M | 182.00M | 133.00M | 128.00M | 165.00M |
| Depreciation & Amortization | 4.81B | 4.78B | 4.71B | 4.80B | 4.45B | 4.07B | 4.03B | 4.04B | 4.15B | 3.67B | 2.91B | 3.43B | 3.46B | 3.68B | 3.86B | 4.22B | 4.08B | 3.51B | 3.01B | 3.07B |
| EBITDA | 20.22B | 17.39B | 16.23B | 8.92B | 9.45B | 16.43B | 20.28B | 9.38B | 7.60B | 5.87B | 3.69B | 6.27B | 9.59B | 8.68B | 698.00M | 1.37B | 14.43B | 14.05B | 12.15B | 9.97B |
| EBITDA Ratio | 14.66% | 12.33% | 13.50% | 8.68% | 8.93% | 11.01% | 9.39% | 8.23% | 8.28% | 7.29% | 5.63% | 5.23% | 6.17% | 8.23% | 3.05% | 4.95% | 11.39% | 10.55% | 10.01% | 9.14% |
| Operating Income | 10.71B | 8.97B | 9.35B | 2.56B | 4.21B | 7.48B | 5.10B | 3.12B | 3.45B | 2.19B | 784.00M | 64.00M | 1.88B | 4.33B | -1.66B | 807.00M | 10.49B | 9.46B | 8.36B | 6.93B |
| Operating Income Ratio | 7.77% | 6.43% | 7.33% | 2.39% | 3.49% | 5.95% | 4.32% | 2.87% | 3.15% | 2.21% | 0.88% | 0.07% | 1.84% | 4.11% | -1.90% | 0.71% | 7.86% | 7.32% | 6.79% | 5.85% |
| Total Other Income/Expenses | 4.68B | 3.61B | 2.13B | 1.54B | 766.00M | 4.84B | 11.09B | 2.14B | 2.24B | 909.00M | 1.70B | 2.63B | 4.09B | -623.00M | -1.69B | -3.87B | -317.00M | 935.00M | 648.00M | -199.00M |
| Income Before Tax | 15.39B | 12.58B | 11.49B | 4.10B | 4.97B | 12.33B | 16.19B | 5.26B | 5.68B | 3.10B | 2.48B | 2.69B | 5.97B | 3.70B | -3.35B | -3.06B | 10.17B | 10.40B | 9.01B | 6.73B |
| Income Before Tax Ratio | 11.16% | 9.02% | 9.00% | 3.83% | 4.12% | 9.80% | 13.73% | 4.84% | 5.18% | 3.13% | 2.80% | 2.98% | 5.85% | 3.51% | -3.83% | -2.71% | 7.63% | 8.05% | 7.31% | 5.69% |
| Income Tax Expense | 3.86B | 2.53B | 2.40B | 1.25B | 1.41B | 2.36B | 2.58B | 861.00M | 989.00M | 994.00M | 1.21B | 943.00M | 997.00M | 1.22B | 916.00M | 3.59B | 3.88B | 4.10B | 3.45B | 2.13B |
| Net Income | 11.48B | 10.02B | 9.07B | 2.81B | 3.42B | 9.71B | 13.43B | 4.11B | 4.41B | 2.06B | 1.31B | 1.64B | 4.47B | 1.86B | -4.50B | -6.86B | 5.67B | 5.80B | 5.03B | 4.00B |
| Net Income Ratio | 8.32% | 7.19% | 7.10% | 2.62% | 2.83% | 7.72% | 11.39% | 3.77% | 4.02% | 2.08% | 1.48% | 1.82% | 4.37% | 1.76% | -5.14% | -6.07% | 4.25% | 4.48% | 4.08% | 3.38% |
| EPS | 396.46 | 347.26 | 314.12 | 97.24 | 118.58 | 675.74 | 935.57 | 286.12 | 307.32 | 143.40 | 89.10 | 110.20 | 319.90 | 131.60 | -313.12 | -468.24 | 383.60 | 392.00 | 335.00 | 264.30 |
| EPS Diluted | 396.46 | 347.26 | 314.12 | 97.24 | 118.58 | 675.74 | 935.57 | 286.12 | 307.32 | 143.40 | 89.10 | 110.20 | 319.90 | 131.60 | -313.12 | -468.24 | 383.60 | 392.00 | 335.00 | 264.30 |
| Weighted Avg Shares Out | 28.96M | 28.87M | 28.87M | 28.86M | 28.80M | 14.37M | 14.36M | 14.36M | 14.36M | 14.36M | 14.75M | 14.91M | 13.97M | 14.12M | 14.37M | 14.65M | 14.78M | 14.79M | 15.01M | 15.13M |
| Weighted Avg Shares Out (Dil) | 28.96M | 28.87M | 28.87M | 28.86M | 28.80M | 14.37M | 14.36M | 14.36M | 14.36M | 14.36M | 14.75M | 14.91M | 13.97M | 14.12M | 14.37M | 14.65M | 14.78M | 14.79M | 15.01M | 15.13M |
Source: https://incomestatements.info
Category: Stock Reports